340B Drug Pricing Program
Congress is back in Washington, D.C., and part of its focus will be passing a package that funds the federal government through October.
The COVID-19 pandemic has altered hospitals’ payer mix, which for some hospitals has temporarily lowered their
disproportionate share hospital (DSH) percentage. These changes have unfortunately threatened the ability of some
hospitals to maintain their eligibility for the 340B program – a vital…
Updates on 340B Legislation, Representatives Letter to HHS
The Supreme Court of the United States today heard oral arguments in a case brought by the AHA and others asking the court to reverse the 2020 federal appeals court decision that upheld the authority of the Department of Health and Human Services to significantly cut payments to certain hospitals…
With a few hours to digest this morning’s oral argument in American Hospital Association v. Becerra, I wanted provide a few high-level reactions.
The Supreme Court of the United States today, Nov. 30 will hear oral arguments in a case brought by the AHA and others asking the court to reverse the 2020 federal appeals court decision that upheld the authority of the Department of Health and Human Services to significantly cut payments to…
Congress is back in Washington, D.C. this week with a number of major priorities to tackle before the end of the year. Congress could act as soon as this week on some of these year-end items so it is important that you weigh in now.
The Supreme Court of the United States Nov. 30 will hear oral arguments in a case brought by the AHA and others asking the court to reverse the 2020 federal appeals court decision that upheld the authority of the Department of Health and Human Services to significantly cut payments to certain…
The AHA last Friday called the government’s defense of the decision by the Department of Health and Human Services to cut reimbursement to certain hospitals participating in the 340B program by nearly 30% “meritless” as it again urged the U.S. Supreme Court to overturn a lower court decision…
The government does not dispute that the agency singled out Section 340B hospitals as a group and set their reimbursement based on acquisition cost rather than price, without conducting the cost study that the statute requires. The agency’s action was therefore contrary to law.